RIA
HZNP

Realta Investment Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Realta Investment Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-80
Closed -$3K – 1613
2019
Q4 		$3K Buy
+80
New +$2.45K ﹤0.01% 1456
2019
Q3 		– Sell
-300
Closed -$7K – 1893
2019
Q2 		$7K Buy
+300
New +$7.61K ﹤0.01% 1286

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Realta Investment Advisors's HZNP Position: Q1 2020 in Review

Realta Investment Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2020, closing a stake of 80 shares — an estimated $3K sold.

Realta Investment Advisors first reported a position in HZNP in Q2 2019 and held it in 2 quarters. The position peaked at $7K in Q2 2019. 295 funds tracked by Wall St. Rank hold HZNP as of Q1 2020.

  • Realta Investment Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 80 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2020, an estimated $3K.
  • Realta Investment Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 2 quarters.
  • Realta Investment Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7K in Q2 2019.
  • 295 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.